A Busy Week for Six Biotech Stocks

by Web Master, Benzinga Editor

June 20, 2011 6:46 AM | 5 seconds read | Make a Comment

Acura, Pain Therapeutics and Fibrocell deal with FDA approval decisions while Curis presents new cancer drug data.

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.